Advanced Medical Isotope Corporation (trading symbol QB:ADMD)
1021 N. Kellogg St. Kennewick, Washington 99336 US
T: 509.736.4000 F: 509.736.4007 E: info@isotopeworld.com

Tags

Latest News

Advanced Medical Isotope CEO Issues Letter to Shareholders Issues Full Status Update, Planned FDA Submission Pathway and Business Plan for 2017 and Beyond

(Wed, 11, Jan 2017) >> read more

 

Advanced Medical Isotope announced today that Dr. Michael Korenko, Ph. D., who formerly served as an advisor to the Board, was named as AMI's interim President and Chief Executive Officer, replacing James Katzaroff.

(Tue, 20, Dec 2016) >> read more

 

Advanced Medical Isotope announced today that it has been awarded in the Superior Court of the State of Washington in and for Benton County, a total judgment of $527,875.74 USD. 
(Fri, 2, Dec 2016) >> read more

 

Advanced Medical Isotope announced today that it will be presenting at the 9th annual LD Micro Main Event on Tuesday, December 6th at 9 AM PST / 12 PM EST at the Luxe Sunset Boulevard Hotel in Los Angeles, CA.
(Wed, 30, Nov 2016) >> read more

 

 Click here for more news and updates

Social Media


  • Empowering Physicians & Medical Researchers

  • Creating Hope with Medical Isotope Technologies

  • Redefining Brachytherapy Cancer Treatments

Advanced Medical Isotope Corporation (AMI)

is a late stage radiation oncology focused medical device company engaged in the development of yttrium-90 based brachytherapy devices for the treatment of non-resectable tumors.


Any sufficiently advanced technology is indistinguishable from magic.

– English physicist and visionary author - Arthur C. Clarke